PHARMARESEARCH BIO Statistics

Total Valuation

XKON:217950 has a market cap or net worth of KRW 143.87 billion.

Market Cap	143.87B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

XKON:217950 has 4.05 million shares outstanding.

Current Share Class	4.05M
Shares Outstanding	4.05M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.07%
Owned by Institutions (%)	n/a
Float	1.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	807.38
PB Ratio	-170.42
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.28

Current Ratio	9.28
Quick Ratio	9.23
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.51
Interest Coverage	-6.18

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-162.00%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.54% in the last 52 weeks. The beta is 0.24, so XKON:217950's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	+35.54%
50-Day Moving Average	41,227.00
200-Day Moving Average	34,077.00
Relative Strength Index (RSI)	31.54
Average Volume (20 Days)	4,232

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XKON:217950 had revenue of KRW 178.19 million and -883.52 million in losses. Loss per share was -22,088.06.

Revenue	178.19M
Gross Profit	161.36M
Operating Income	-759.75M
Pretax Income	-883.52M
Net Income	-883.52M
EBITDA	-755.07M
EBIT	-759.75M
Loss Per Share	-22,088.06

Full Income Statement

Balance Sheet

The company has 428.99 million in cash and 1.04 billion in debt, giving a net cash position of -614.18 million or -151.76 per share.

Cash & Cash Equivalents	428.99M
Total Debt	1.04B
Net Cash	-614.18M
Net Cash Per Share	-151.76
Equity (Book Value)	-844.19M
Book Value Per Share	-21,104.73
Working Capital	385.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -386.65 million and capital expenditures -29.10 million, giving a free cash flow of -415.75 million.

Operating Cash Flow	-386.65M
Capital Expenditures	-29.10M
Free Cash Flow	-415.75M
FCF Per Share	-102.73

Full Cash Flow Statement

Margins

Gross Margin	90.55%
Operating Margin	-426.37%
Pretax Margin	-495.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XKON:217950 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.61%
FCF Yield	-0.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XKON:217950 has an Altman Z-Score of -6.67 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.67
Piotroski F-Score	1